lamotrigine has been researched along with Syndrome in 41 studies
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a double-blind, placebo-controlled trial of the antiepileptic drug lamotrigine in patients with the Lennox-Gastaut syndrome." | 9.08 | Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. ( Arvidsson, JF; Barrera, MN; Manasco, P; Motte, J; Mullens, EL; Trevathan, E, 1997) |
| " We herein present an unusual case of DRESS syndrome due to lamotrigine with reactivation of Epstein-Barr virus, which developed autoimmune LE and syndrome of inappropriate antidiuretic hormone secretion." | 7.83 | Autoimmune Limbic Encephalitis and Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Lamotrigine-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. ( Ozisik, L; Saka, E; Tanriover, MD, 2016) |
| " We report here a case of Drug Reaction with Eosinophilia and Systemic Symptoms apparently precipitated by the associated use of lamotrigine and cyclobenzaprine." | 7.78 | Erythema multiforme vs. DRESS syndrome associated with the combined use of lamotrigine and cyclobenzaprine: a case report. ( Bicknell, LT; Sanches, M; Schatte, DJ, 2012) |
| "To report a case of lamotrigine-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome with pancreatitis as the initial visceral involvement." | 7.76 | First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis. ( Augusto, JF; Croue, A; Dib, N; Lerolle, N; Mercat, A; Peres, M; Roquin, G, 2010) |
| "Anticonvulsant hypersensitivity syndrome (AHS) developing to lamotrigine, a non-aromatic anticonvulsant, has rarely been reported." | 7.73 | Anticonvulsant hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. ( Gogtay, NJ; Kanchan, S; Karande, S; Kshirsagar, NA, 2006) |
| "If the positive effect of lamotrigine in patients with SUNCT is confirmed in other cases, lamotrigine could become the first specific treatment for SUNCT syndrome." | 7.71 | SUNCT syndrome responsive to lamotrigine. ( Gutierrez-Garcia, JM, 2002) |
| "An 8-year-old girl with Lennox-Gastaut syndrome showed a partial reduction in seizure frequency when lamotrigine (LTG), 15 mg/kg per day, was added to clobazam (CLB) and vigabatrin (VGB)." | 7.70 | Myoclonic status epilepticus following high-dosage lamotrigine therapy. ( Belmonte, A; Guerrini, R; Parmeggiani, L; Perucca, E, 1999) |
| "The SUNCT syndrome is characterized by a short-lasting headache in the first division of the trigeminal nerve, associated with ipsilateral autonomic symptoms." | 6.42 | Influence of lamotrigine over the SUNCT syndrome: one patient follow-up for two years. ( Kowacs, PA; Piovesan, EJ; Siow, C; Werneck, LC, 2003) |
| "The syndrome is characterized by mental impairment, frequent seizures of multiple types that are particularly resistant to treatment, and high rates of seizure-related injury." | 5.36 | The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK. ( Benedict, A; Maclaine, G; Verdian, L, 2010) |
| "Lamotrigine was replaced by sodium valproate for one patient." | 5.33 | [Drug hypersensitivity syndrome with lamotrigine two cases in elderly]. ( Bourdel-Marchasson, I; Jeandel, PY; Rainfray, M; Traissac, T, 2005) |
| "We conducted a double-blind, placebo-controlled trial of the antiepileptic drug lamotrigine in patients with the Lennox-Gastaut syndrome." | 5.08 | Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. ( Arvidsson, JF; Barrera, MN; Manasco, P; Motte, J; Mullens, EL; Trevathan, E, 1997) |
| "Accumulating data suggest that lamotrigine, which has been available for adult use in epilepsy for more than a decade in clinical practice, also confers effective, well-tolerated control of a range of childhood epilepsies." | 4.81 | Efficacy and safety of lamotrigine in pediatric patients. ( Messenheimer, J, 2002) |
| " We herein present an unusual case of DRESS syndrome due to lamotrigine with reactivation of Epstein-Barr virus, which developed autoimmune LE and syndrome of inappropriate antidiuretic hormone secretion." | 3.83 | Autoimmune Limbic Encephalitis and Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Lamotrigine-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. ( Ozisik, L; Saka, E; Tanriover, MD, 2016) |
| " We report here a case of Drug Reaction with Eosinophilia and Systemic Symptoms apparently precipitated by the associated use of lamotrigine and cyclobenzaprine." | 3.78 | Erythema multiforme vs. DRESS syndrome associated with the combined use of lamotrigine and cyclobenzaprine: a case report. ( Bicknell, LT; Sanches, M; Schatte, DJ, 2012) |
| " All had dermatological manifestations, eosinophilia and systemic (haematological and hepatic) manifestations that could be attributed to treatment with aromatic AEDs (carbamazepine, 2 patients; lamotrigine, 3 patients; phenytoin, 3 patients)." | 3.77 | Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs. ( Kochen, S; Pereira de Silva, N; Piquioni, P; Saidon, P, 2011) |
| "To report a case of lamotrigine-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome with pancreatitis as the initial visceral involvement." | 3.76 | First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis. ( Augusto, JF; Croue, A; Dib, N; Lerolle, N; Mercat, A; Peres, M; Roquin, G, 2010) |
| "This report describes the laboratory and physical manifestations of lamotrigine-like toxicity in a young man with refractory epilepsy receiving lamotrigine presenting as anticonvulsant hypersensitivity syndrome (AHS) associated with an abrupt change of drug product." | 3.74 | Progressive anticonvulsant hypersensitivity syndrome associated with change of drug product. ( Sabers, A; Sabroe, TP, 2008) |
| "Anticonvulsant hypersensitivity syndrome (AHS) developing to lamotrigine, a non-aromatic anticonvulsant, has rarely been reported." | 3.73 | Anticonvulsant hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. ( Gogtay, NJ; Kanchan, S; Karande, S; Kshirsagar, NA, 2006) |
| "If the positive effect of lamotrigine in patients with SUNCT is confirmed in other cases, lamotrigine could become the first specific treatment for SUNCT syndrome." | 3.71 | SUNCT syndrome responsive to lamotrigine. ( Gutierrez-Garcia, JM, 2002) |
| "An 8-year-old girl with Lennox-Gastaut syndrome showed a partial reduction in seizure frequency when lamotrigine (LTG), 15 mg/kg per day, was added to clobazam (CLB) and vigabatrin (VGB)." | 3.70 | Myoclonic status epilepticus following high-dosage lamotrigine therapy. ( Belmonte, A; Guerrini, R; Parmeggiani, L; Perucca, E, 1999) |
| " The further addition of lamotrigine stopped the seizures but the patient presented with a new onset of opercular syndrome, manifested by severe oral motor apraxia with difficulties in chewing and swallowing and speech." | 3.70 | Transient opercular syndrome: a manifestation of uncontrolled epileptic activity. ( Mimouni, M; Shuper, A; Stahl, B, 2000) |
| " Future studies of formal pharmacokinetic modeling of AEDs during pregnancy and the postpartum period could provide an important step toward achieving effective drug dosing to maintain therapeutic objectives for the mother but, at the same time, to minimize fetal drug exposure." | 2.42 | Antiepileptic drug pharmacokinetics during pregnancy and lactation. ( Pennell, PB, 2003) |
| "The SUNCT syndrome is characterized by a short-lasting headache in the first division of the trigeminal nerve, associated with ipsilateral autonomic symptoms." | 2.42 | Influence of lamotrigine over the SUNCT syndrome: one patient follow-up for two years. ( Kowacs, PA; Piovesan, EJ; Siow, C; Werneck, LC, 2003) |
| " Dosing in generalized seizures is similar to that for partial seizures." | 2.40 | Lamotrigine in absence and primary generalized epilepsies. ( Holmes, GL; Mikati, MA, 1997) |
| "Lamotrigine was beneficial for her SUNA but not for the RES." | 1.39 | SUNA and red ear syndrome: a new association and pathophysiological considerations. ( Bakar, NA; Lambru, G; Matharu, M, 2013) |
| "The syndrome is characterized by mental impairment, frequent seizures of multiple types that are particularly resistant to treatment, and high rates of seizure-related injury." | 1.36 | The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK. ( Benedict, A; Maclaine, G; Verdian, L, 2010) |
| "Although epilepsy in AS is considered a generalized epilepsy, there was a high prevalence of partial seizures." | 1.35 | Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options. ( Braun, EK; Bruno, P; Conant, KD; Nespeca, MP; Said, RR; Thibert, RL; Thiele, EA, 2009) |
| "Epilepsy is often the most important clinical manifestation of the syndrome, even if its appearance is not constantly precocious." | 1.35 | Ring chromosome 20 syndrome: a link between epilepsy onset and neuropsychological impairment in three children. ( Canevini, MP; Dalla Bernardina, B; Darra, F; Fiorini, E; La Selva, L; Lazzarotto, F; Piazzini, A; Vignoli, A; Zucca, C, 2009) |
| "Lamotrigine was replaced by sodium valproate for one patient." | 1.33 | [Drug hypersensitivity syndrome with lamotrigine two cases in elderly]. ( Bourdel-Marchasson, I; Jeandel, PY; Rainfray, M; Traissac, T, 2005) |
| "This syndrome is accompanied by fever, rash, lymphadenopathy, eosinophilia and affects parenchymal organs." | 1.32 | [Anticonvulsant hypersensitivity syndrome]. ( Papp, Z; Török, L, 2004) |
| "Chorea is a rare side effect of anticonvulsants." | 1.31 | Anticonvulsants-induced chorea: a role for pharmacodynamic drug interaction? ( Beach, RL; D'Cruz, O; Tennison, M; Zaatreh, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (19.51) | 18.2507 |
| 2000's | 19 (46.34) | 29.6817 |
| 2010's | 12 (29.27) | 24.3611 |
| 2020's | 2 (4.88) | 2.80 |
| Authors | Studies |
|---|---|
| Watkins, LV | 1 |
| O'Dwyer, M | 1 |
| Shankar, R | 1 |
| Packard, E | 1 |
| Kalayanamitra, R | 1 |
| Shahid, Z | 1 |
| Patel, R | 1 |
| Roy, J | 1 |
| Maddukari, A | 1 |
| Groff, A | 1 |
| Polimera, H | 1 |
| Golamari, R | 1 |
| Sahu, N | 1 |
| Vunnam, R | 1 |
| Bhatt, D | 1 |
| Jain, R | 1 |
| Wiedemann, K | 1 |
| Stüber, T | 1 |
| Rehn, M | 1 |
| Frieauff, E | 1 |
| Salgado, A | 1 |
| Oliveira, L | 1 |
| Sierra-Siegert, M | 1 |
| Salgado, JV | 1 |
| Lambru, G | 1 |
| Bakar, NA | 1 |
| Matharu, M | 1 |
| Bicknell, LT | 1 |
| Sanches, M | 1 |
| Schatte, DJ | 1 |
| Pulido Fontes, L | 1 |
| Mayor Gómez, S | 1 |
| Ozisik, L | 1 |
| Tanriover, MD | 1 |
| Saka, E | 1 |
| Taillia, H | 1 |
| Alla, P | 1 |
| Fournier, B | 1 |
| Bounolleau, P | 1 |
| Ouologem, M | 1 |
| Ricard, D | 1 |
| Sallansonnet-Froment, M | 1 |
| de Greslan, T | 1 |
| Renard, JL | 1 |
| Thibert, RL | 1 |
| Conant, KD | 1 |
| Braun, EK | 1 |
| Bruno, P | 1 |
| Said, RR | 1 |
| Nespeca, MP | 1 |
| Thiele, EA | 1 |
| Vignoli, A | 1 |
| Canevini, MP | 1 |
| Darra, F | 1 |
| La Selva, L | 1 |
| Fiorini, E | 1 |
| Piazzini, A | 1 |
| Lazzarotto, F | 1 |
| Zucca, C | 1 |
| Dalla Bernardina, B | 1 |
| Aouam, K | 1 |
| Ben Romdhane, F | 1 |
| Loussaief, C | 1 |
| Salem, R | 1 |
| Toumi, A | 1 |
| Belhadjali, H | 1 |
| Chaabane, A | 1 |
| Boughattas, NA | 1 |
| Chakroun, M | 1 |
| Benedict, A | 1 |
| Verdian, L | 1 |
| Maclaine, G | 1 |
| Sepić-Grahovac, D | 1 |
| Ruzić Barsić, A | 1 |
| Ruzić, K | 1 |
| Grahovac, T | 1 |
| Dadić-Hero, E | 1 |
| Roquin, G | 1 |
| Peres, M | 1 |
| Lerolle, N | 1 |
| Dib, N | 1 |
| Mercat, A | 1 |
| Croue, A | 1 |
| Augusto, JF | 1 |
| Pereira de Silva, N | 1 |
| Piquioni, P | 1 |
| Kochen, S | 1 |
| Saidon, P | 1 |
| Marriott, DJ | 1 |
| Periyasamy, P | 1 |
| Sato, T | 1 |
| Kuniba, H | 1 |
| Matsuo, M | 1 |
| Matsuzaka, T | 1 |
| Moriuchi, H | 1 |
| Gutierrez-Garcia, JM | 1 |
| Bourgeois, BF | 1 |
| Pennell, PB | 1 |
| Piovesan, EJ | 1 |
| Siow, C | 1 |
| Kowacs, PA | 1 |
| Werneck, LC | 1 |
| Papp, Z | 1 |
| Török, L | 1 |
| Jeandel, PY | 1 |
| Traissac, T | 1 |
| Rainfray, M | 1 |
| Bourdel-Marchasson, I | 1 |
| Benbadis, SR | 1 |
| Karande, S | 1 |
| Gogtay, NJ | 1 |
| Kanchan, S | 1 |
| Kshirsagar, NA | 1 |
| Kilaru, S | 1 |
| Bergqvist, AGC | 1 |
| Sabroe, TP | 1 |
| Sabers, A | 1 |
| Motte, J | 1 |
| Trevathan, E | 1 |
| Arvidsson, JF | 1 |
| Barrera, MN | 1 |
| Mullens, EL | 1 |
| Manasco, P | 1 |
| Dulac, O | 1 |
| Kaminska, A | 1 |
| Mikati, MA | 1 |
| Holmes, GL | 1 |
| Tugendhaft, P | 1 |
| Simonart, T | 1 |
| Kukushkin, ML | 1 |
| Danilova, EI | 1 |
| Grafova, VN | 1 |
| Smirnova, VS | 1 |
| Reshetniak, VK | 1 |
| Bélanger, S | 1 |
| Coulombe, G | 1 |
| Carmant, L | 1 |
| Guerrini, R | 1 |
| Belmonte, A | 1 |
| Parmeggiani, L | 1 |
| Perucca, E | 1 |
| D'Andrea, G | 1 |
| Granella, F | 1 |
| Cadaldini, M | 1 |
| Shuper, A | 1 |
| Stahl, B | 1 |
| Mimouni, M | 1 |
| Leone, M | 1 |
| Rigamonti, A | 1 |
| Usai, S | 1 |
| Damico, D | 1 |
| Grazzi, L | 1 |
| Bussone, G | 1 |
| Tilignac, C | 1 |
| Dordain, G | 1 |
| Zaatreh, M | 1 |
| Tennison, M | 1 |
| D'Cruz, O | 1 |
| Beach, RL | 1 |
| Messenheimer, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study of Maternal Pharmacokinetic and Placental Transfer of Levetiracetam[NCT04117425] | 50 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | |||
| Verapamil as Adjunctive Seizure Therapy for Children and Young Adults With Dravet Syndrome[NCT01607073] | Phase 2 | 2 participants (Actual) | Interventional | 2012-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The secondary outcome measure is the change in number of absence seizures from Week 8 (Baseline) to Week 12 (NCT01607073)
Timeframe: Week 8 to Week 12
| Intervention | Abscence seizures (Number) |
|---|---|
| Week 8 Baseline | 165 |
| Week 12 Verapamil 4mg/kg/Day | 101 |
The primary study endpoint is the change in number of seizures from baseline. Since we only had one participant finish the study, the endpoint was changed to Week 12 visit. Participants were on verapamil for 4 weeks at Week 12. (NCT01607073)
Timeframe: Week 8 (baseline) to Week 12
| Intervention | General tonic-clonic seizures (Number) |
|---|---|
| Week 8 Baseline | 39 |
| Week 12 Verapamil 4mg/kg/Day | 14 |
The secondary outcome is the change in number of myoclonic seizures between baseline Week 8 visit and Week 12 visit. (NCT01607073)
Timeframe: Week 8 (baseline) to Week 12
| Intervention | Myoclonic seizures (Number) |
|---|---|
| Week 8 Baseline | 116 |
| Week 12 Verapamil 4mg/kg/Day | 175 |
8 reviews available for lamotrigine and Syndrome
| Article | Year |
|---|---|
A review of the pharmacotherapeutic considerations for managing epilepsy in people with autism.
Topics: Anticonvulsants; Autistic Disorder; Epilepsy; Humans; Lamotrigine; Syndrome | 2022 |
Chronic management of seizures in the syndromes of idiopathic generalized epilepsy.
Topics: Adult; Anticonvulsants; Child; Clinical Trials as Topic; Epilepsy, Generalized; Fructose; Humans; La | 2003 |
Antiepileptic drug pharmacokinetics during pregnancy and lactation.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Epilepsy; Female; Fetal Diseases; Fetal Hypoxia | 2003 |
Influence of lamotrigine over the SUNCT syndrome: one patient follow-up for two years.
Topics: Analgesics; Headache; Humans; Lamotrigine; Male; Middle Aged; Syndrome; Triazines | 2003 |
Practical management issues for idiopathic generalized epilepsies.
Topics: Age Factors; Age of Onset; Anticonvulsants; Electric Stimulation Therapy; Epilepsy, Generalized; Hum | 2005 |
Use of lamotrigine in Lennox-Gastaut and related epilepsy syndromes.
Topics: Anticonvulsants; Child; Diagnosis, Differential; Epilepsy; Epilepsy, Generalized; Humans; Lamotrigin | 1997 |
Lamotrigine in absence and primary generalized epilepsies.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Epilepsy, Absence; Epilepsy, Generalize | 1997 |
Efficacy and safety of lamotrigine in pediatric patients.
Topics: Anticonvulsants; Child; Clinical Trials as Topic; Epilepsy; Humans; Lamotrigine; Syndrome; Treatment | 2002 |
1 trial available for lamotrigine and Syndrome
| Article | Year |
|---|---|
Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Double-Blind Method; Epilepsy; Female; | 1997 |
32 other studies available for lamotrigine and Syndrome
| Article | Year |
|---|---|
DRESS is a Mess: A Case of Cross Reactivity Between Lacosamide and Lamotrigine.
Topics: Anticonvulsants; Eosinophilia; Humans; Lacosamide; Lamotrigine; Syndrome | 2021 |
Fetal Valproate Syndrome - Still a Problem Today!
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Cesarean Section; Drug Therapy, Combination; Ep | 2017 |
Depersonalization and derealization syndrome: report on a case study and pharmacological management.
Topics: Adult; Cyclohexanols; Depersonalization; Female; Humans; Lamotrigine; Selective Serotonin Reuptake I | 2012 |
SUNA and red ear syndrome: a new association and pathophysiological considerations.
Topics: Ear Diseases; Erythema; Excitatory Amino Acid Antagonists; Female; Humans; Lamotrigine; Middle Aged; | 2013 |
Erythema multiforme vs. DRESS syndrome associated with the combined use of lamotrigine and cyclobenzaprine: a case report.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Antimanic Agents; Citalopram; Diagnosis, Differenti | 2012 |
SUNCT (Short-lasting unilateral neuralgiform headache attack with conjunctival injection and tearing) associated with pituitary lesion.
Topics: Excitatory Amino Acid Antagonists; Headache; Humans; Lamotrigine; Magnetic Resonance Imaging; Male; | 2015 |
Autoimmune Limbic Encephalitis and Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Lamotrigine-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.
Topics: Adult; Anticonvulsants; Autoimmune Diseases; Drug Hypersensitivity; Eosinophilia; Exanthema; Female; | 2016 |
[Anticonvulsant hypersensitivity syndrome and lamotrigine-associated anticonvulsant hypersensitivity syndrome].
Topics: Adult; Aged; Anticonvulsants; Bipolar Disorder; Drug Eruptions; Drug Hypersensitivity; Eosinophilia; | 2009 |
Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options.
Topics: Adolescent; Adult; Angelman Syndrome; Anticonvulsants; Child; Child, Preschool; Clonazepam; Comorbid | 2009 |
Ring chromosome 20 syndrome: a link between epilepsy onset and neuropsychological impairment in three children.
Topics: Adult; Age of Onset; Anticonvulsants; Child; Chromosomes, Human, Pair 20; Cognition Disorders; Comor | 2009 |
Hypersensitivity syndrome induced by anticonvulsants: possible cross-reactivity between carbamazepine and lamotrigine.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Cross Reactions; Drug Eruptions; Drug Hypersensitivity; | 2009 |
The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Computer Simulation; Cost-Benefit Analy | 2010 |
Neurological and psychiatric aspects of corpus callosum genesis.
Topics: Acrocallosal Syndrome; Adult; Amnesia; Anticonvulsants; Apraxias; Epilepsy, Generalized; Functional | 2010 |
First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis.
Topics: Aged; Drug Eruptions; Eosinophilia; Exanthema; Humans; Lamotrigine; Male; Pancreatitis; Syndrome; Tr | 2010 |
Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anticonvulsants; Carbamazepine; Disease Susceptibility; | 2011 |
Anticonvulsant hypersensitivity syndrome secondary to lamotrigine mimicking a septic episode.
Topics: Animals; Anticonvulsants; Cattle; Drug Hypersensitivity; Female; Humans; Lamotrigine; Lupus Erythema | 2011 |
[Case of drug-induced hypersensitivity syndrome due to lamotrigine: demonstration of sequential reactivation of herpesviruses].
Topics: Adolescent; Anticonvulsants; Cytomegalovirus; Drug Hypersensitivity; Female; Herpesvirus 4, Human; H | 2012 |
SUNCT syndrome responsive to lamotrigine.
Topics: Adult; Analgesics; Anticonvulsants; Conjunctiva; Female; Headache Disorders; Humans; Lamotrigine; Ma | 2002 |
[Anticonvulsant hypersensitivity syndrome].
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Eruptions; Drug | 2004 |
[Drug hypersensitivity syndrome with lamotrigine two cases in elderly].
Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Drug Hypersensitivity; Epilepsy; Female; Huma | 2005 |
Anticonvulsant hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro.
Topics: Anticonvulsants; Child, Preschool; Drug Hypersensitivity; Epilepsy; Humans; In Vitro Techniques; Lam | 2006 |
Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia.
Topics: Age of Onset; Anticonvulsants; Child; Cognition Disorders; Dietary Fats; Electroencephalography; Epi | 2007 |
Progressive anticonvulsant hypersensitivity syndrome associated with change of drug product.
Topics: Adult; Anticonvulsants; Arthralgia; Arthritis; Drugs, Generic; Epilepsy; Exanthema; Fever; Humans; L | 2008 |
Phenytoin-like hypersensitivity associated with lamotrigine.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Drug Eruptions; Exanthema; Humans; Lamotrigine; P | 1998 |
[Effect of lamotrigine on development of neurogenic pain syndrome in rats].
Topics: Analgesics; Animals; Anticonvulsants; Convulsants; Lamotrigine; Neurons; Pain; Pain Measurement; Pen | 1998 |
Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; | 1998 |
Myoclonic status epilepticus following high-dosage lamotrigine therapy.
Topics: Anticonvulsants; Child; Electroencephalography; Epilepsies, Myoclonic; Epilepsy, Absence; Female; Hu | 1999 |
Possible usefulness of lamotrigine in the treatment of SUNCT syndrome.
Topics: Aged; Calcium Channel Blockers; Conjunctival Diseases; Dose-Response Relationship, Drug; Female; Hea | 1999 |
Transient opercular syndrome: a manifestation of uncontrolled epileptic activity.
Topics: Anticonvulsants; Child; Diagnosis, Differential; Electroencephalography; Epilepsy, Frontal Lobe; Hum | 2000 |
Two new SUNCT cases responsive to lamotrigine.
Topics: Aged; Conjunctival Diseases; Female; Headache; Humans; Lacrimal Apparatus Diseases; Lamotrigine; Mal | 2000 |
[SUNCT syndrome sensitive to lamotrigine].
Topics: Analgesics; Cerebrospinal Fluid Rhinorrhea; Conjunctival Diseases; Female; Functional Laterality; He | 2001 |
Anticonvulsants-induced chorea: a role for pharmacodynamic drug interaction?
Topics: Anticonvulsants; Child, Preschool; Chorea; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Dr | 2001 |